Literature DB >> 30753831

Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells.

Courtney L Jones, Brett M Stevens, Angelo D'Alessandro, Julie A Reisz, Rachel Culp-Hill, Travis Nemkov, Shanshan Pei, Nabilah Khan, Biniam Adane, Haobin Ye, Anna Krug, Dominik Reinhold, Clayton Smith, James DeGregori, Daniel A Pollyea, Craig T Jordan.   

Abstract

Entities:  

Year:  2019        PMID： 30753831      PMCID： PMC6389327          DOI： 10.1016/j.ccell.2019.01.013

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  10 in total

Review 1.  Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy.

Authors:  Jenna L Carter; Katie Hege; Jay Yang; Hasini A Kalpage; Yongwei Su; Holly Edwards; Maik Hüttemann; Jeffrey W Taub; Yubin Ge
Journal:  Signal Transduct Target Ther       Date:  2020-12-18

2.  Development and Validation of an Individualized Metabolism-Related Prognostic Model for Adult Acute Myeloid Leukemia Patients.

Authors:  Cong Wei; Lijuan Ding; Qian Luo; Xiaoqing Li; Xiangjun Zeng; Delin Kong; Xiaohong Yu; Jingjing Feng; Yishan Ye; Limengmeng Wang; He Huang
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

Review 3.  Targeting mitochondrial respiration for the treatment of acute myeloid leukemia.

Authors:  Jenna L Carter; Katie Hege; Hasini A Kalpage; Holly Edwards; Maik Hüttemann; Jeffrey W Taub; Yubin Ge
Journal:  Biochem Pharmacol       Date:  2020-10-02       Impact factor: 5.858

4.  Aldehyde dehydrogenase 3a2 protects AML cells from oxidative death and the synthetic lethality of ferroptosis inducers.

Authors:  Rushdia Zareen Yusuf; Borja Saez; Azeem Sharda; Nick van Gastel; Vionnie W C Yu; Ninib Baryawno; Elizabeth W Scadden; Sanket Acharya; Shrikanta Chattophadhyay; Cherrie Huang; Vasanthi Viswanathan; Dana S'aulis; Julien Cobert; David B Sykes; Mark A Keibler; Sudeshna Das; John N Hutchinson; Michael Churchill; Siddhartha Mukherjee; Dongjun Lee; Francois Mercier; John Doench; Lars Bullinger; David J Logan; Stuart Schreiber; Gregory Stephanopoulos; William B Rizzo; David T Scadden
Journal:  Blood       Date:  2020-09-10       Impact factor: 25.476

Review 5.  Fatty Acid Metabolism, Bone Marrow Adipocytes, and AML.

Authors:  Yoko Tabe; Marina Konopleva; Michael Andreeff
Journal:  Front Oncol       Date:  2020-02-18       Impact factor: 6.244

Review 6.  Mitochondrial metabolism as a target for acute myeloid leukemia treatment.

Authors:  Svetlana B Panina; Jingqi Pei; Natalia V Kirienko
Journal:  Cancer Metab       Date:  2021-04-21

7.  SLC1A5 provides glutamine and asparagine necessary for bone development in mice.

Authors:  Deepika Sharma; Yilin Yu; Leyao Shen; Guo-Fang Zhang; Courtney M Karner
Journal:  Elife       Date:  2021-10-14       Impact factor: 8.140

8.  The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness.

Authors:  Geethu Emily Thomas; Grace Egan; Laura García-Prat; Aaron Botham; Veronique Voisin; Parasvi S Patel; Fieke W Hoff; Jordan Chin; Boaz Nachmias; Kerstin B Kaufmann; Dilshad H Khan; Rose Hurren; Xiaoming Wang; Marcela Gronda; Neil MacLean; Cristiana O'Brien; Rashim P Singh; Courtney L Jones; Shane M Harding; Brian Raught; Andrea Arruda; Mark D Minden; Gary D Bader; Razq Hakem; Steve Kornblau; John E Dick; Aaron D Schimmer
Journal:  Nat Cell Biol       Date:  2022-06-06       Impact factor: 28.213

9.  A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia.

Authors:  Hai-Bin Zhang; Zhuo-Kai Sun; Fang-Min Zhong; Fang-Yi Yao; Jing Liu; Jing Zhang; Nan Zhang; Jin Lin; Shu-Qi Li; Mei-Yong Li; Jun-Yao Jiang; Ying Cheng; Shuai Xu; Xue-Xin Cheng; Bo Huang; Xiao-Zhong Wang
Journal:  Lipids Health Dis       Date:  2022-08-25       Impact factor: 4.315

Review 10.  Amino Acid Metabolic Vulnerabilities in Acute and Chronic Myeloid Leukemias.

Authors:  Aboli Bhingarkar; Hima V Vangapandu; Sanjay Rathod; Keito Hoshitsuki; Christian A Fernandez
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.